- T2Bacteria® Panel: It’s the first FDA-cleared and CE-marked test panel capable of identifying six common bacterial pathogens.
- Time Efficiency: Delivers results in 3 to 5 hours directly from a whole blood sample.
- Pathogens Detected: Includes E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and E. coli.
- Clinical Relevance: These bacteria are prevalent in emergency departments and are often responsible for hospital-acquired infections.
- ESKAPE Pathogens: Some detected species are ESKAPE pathogens, known for their virulence and resistance to empiric antimicrobial therapy.
- Impact on Patient Care: Quick identification of these pathogens is crucial for timely and targeted treatment, which can significantly improve patient outcomes.
- 90% Sensitivity
- 98% Specificity
